Reconsidering Low-Dose Bevacizumab Regimens in High-Grade Gliomas: A Policy Brief for Resource-Limited Settings.
- DOI
- 10.31557/apjcp.2026.27.8.2753
- Published
- 2026 Aug 1
- Container
- Asian Pacific journal of cancer prevention : APJCP
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.31557/apjcp.2026.27.8.2753,
title = {Reconsidering Low-Dose Bevacizumab Regimens in High-Grade Gliomas: A Policy Brief for Resource-Limited Settings.},
author = {Parivar Y and Fazilat-Panah D and Welsh JS and Peyro Shabany B and Javadinia SA and Khakshour E},
year = {2026},
journal = {Asian Pacific journal of cancer prevention : APJCP},
doi = {10.31557/apjcp.2026.27.8.2753},
url = {https://doi.org/10.31557/apjcp.2026.27.8.2753}
}RIS
TY - JOUR TI - Reconsidering Low-Dose Bevacizumab Regimens in High-Grade Gliomas: A Policy Brief for Resource-Limited Settings. AU - Parivar Y AU - Fazilat-Panah D AU - Welsh JS AU - Peyro Shabany B AU - Javadinia SA AU - Khakshour E PY - 2026 JO - Asian Pacific journal of cancer prevention : APJCP DO - 10.31557/apjcp.2026.27.8.2753 UR - https://doi.org/10.31557/apjcp.2026.27.8.2753 ER -
APA
Y, P., D, F., JS, W., B, P. S., SA, J., & E, K. (2026). Reconsidering Low-Dose Bevacizumab Regimens in High-Grade Gliomas: A Policy Brief for Resource-Limited Settings.. Asian Pacific journal of cancer prevention : APJCP. https://doi.org/10.31557/apjcp.2026.27.8.2753
Source records
- pubmed · retrieved 2026-09-27T00:23:00.621Z